Hong Jun Liang

Director/Board Member en BEIJING STRONG BIOTECHNOLOGIES,INC. .

50 años

Health Technology

Health Services

Perfil

Hong Jun Liang is currently the Vice Chairman at Beijing Strong Biotechnologies, Inc. and Director at Fuzhou Maixin Biotech Co., Ltd.
Previously, he served as the Chairman-Supervisory Board at Shanghai Shyndec Pharmaceutical Co., Ltd.
and as a Director at Jiangsu Hengrui Pharmaceuticals Co., Ltd.
from 2018 to 2020.

Cargos activos de Hong Jun Liang

Empresas	Cargo	Inicio
BEIJING STRONG BIOTECHNOLOGIES,INC.	Director/Board Member	13/08/2020
Fuzhou Maixin Biotech Co., Ltd. Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang.	Director/Board Member	15/09/2020

Todos los cargos activos de Hong Jun Liang

Antiguos cargos conocidos de Hong Jun Liang.

Empresas	Cargo	Fin
JIANGSU HENGRUI MEDICINE CO., LTD.	Director/Board Member	01/01/2020
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Chairman	15/11/2019

Ver el detalle de la experiencia de Hong Jun Liang.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hong Jun Liang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	3
JIANGSU HENGRUI MEDICINE CO., LTD.	Health Technology
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Health Technology
BEIJING STRONG BIOTECHNOLOGIES,INC.	Health Technology

Empresas privadas	1
Fuzhou Maixin Biotech Co., Ltd. Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang.	Health Services